We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current GH market cap is 2.22B. The company's latest EPS is USD -3.9392 and P/E is -4.64.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 117.4M | 126.89M | 128.71M | 137.15M | 143.03M |
| Operating Income | -144.6M | -146.12M | -134.06M | -119.62M | -113.54M |
| Net Income | -161.99M | -139.93M | -133.53M | -72.77M | -86.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 214.38M | 286.73M | 373.65M | 449.54M | 563.95M |
| Operating Income | -82.37M | -254.95M | -411M | -544.38M | -564.73M |
| Net Income | -75.65M | -253.78M | -405.67M | -654.59M | -479.45M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.7B | 1.61B | 1.51B | 1.84B | 1.8B |
| Total Liabilities | 1.54B | 1.55B | 1.56B | 1.55B | 1.57B |
| Total Equity | 166.75M | 60.18M | -44.55M | 292.73M | 228.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 962.54M | 2.27B | 2.2B | 1.61B | 1.79B |
| Total Liabilities | 114.54M | 916.19M | 1.56B | 1.55B | 1.63B |
| Total Equity | 798.39M | 1.3B | 645.01M | 60.18M | 158.68M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -218.71M | -309.46M | -74.44M | -168.46M | -246.25M |
| Investing | 79.19M | 149.82M | 157.22M | -83.9M | 176.8M |
| Financing | -191.41M | -189.09M | -854k | 383M | 386.81M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -47.13M | -103.93M | -209.02M | -309.46M | -324.98M |
| Investing | -317.57M | -617.09M | -63.16M | 149.82M | 840.25M |
| Financing | 367.3M | 1.41B | -66.82M | -189.09M | 477.38M |
| Market Cap | 2.22B |
| Price to Earnings Ratio | -4.64 |
| Price to Sales Ratio | 3.94 |
| Price to Cash Ratio | 1.96 |
| Price to Book Ratio | 14.01 |
| Dividend Yield | - |
| Shares Outstanding | 121.71M |
| Average Volume (1 week) | 1.43M |
| Average Volume (1 Month) | 1.92M |
| 52 Week Change | -18.12% |
| 52 Week High | 41.06 |
| 52 Week Low | 15.81 |
| Spread (Intraday) | 0.6 (3.19%) |
| Company Name | Guardant Health Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.guardanthealth.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
